AC Immune SA ACIU
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2025Q4 | 3.14 | -14,406 | -14 | |||
| 2025Q3 | 2.89 | -0.16 | -15,699 | -16 | ||
| 2025Q2 | 2.03 | -0.21 | -19,388 | -21 | ||
| 2025Q1 | 1.87 | -0.19 | -19,370 | -19 | ||
| 2024Q4 | 2.70 | -18,618 | -16 | |||
| 2024Q3 | 3.78 | 0.05 | 7,269 | 6 | ||
| 2024Q2 | 3.99 | -0.23 | -20,961 | -23 | ||
| 2024Q1 | 2.96 | -0.18 | -20,068 | -18 | ||
| 2023Q4 | 5.00 | -3,541 | -5 | |||
| 2023Q3 | 2.85 | -0.18 | -15,466 | -15 | ||
| 2023Q2 | 2.96 | -0.20 | -17,046 | -17 | ||
| 2023Q1 | 2.34 | -0.21 | -17,571 | -18 | ||
| 2022Q4 | 2.04 | -0.23 | -18,697 | -19 | ||
| 2022Q3 | 3.16 | -0.16 | -13,463 | -14 | ||
| 2022Q2 | 3.61 | -0.23 | -19,859 | -20 | ||
| 2022Q1 | 4.00 | -0.23 | -18,830 | -19 | ||
| 2021Q4 | 4.95 | -22,787 | -21 | |||
| 2021Q3 | 6.71 | -0.22 | -20,283 | -16 | ||
| 2021Q2 | 7.93 | -0.26 | -18,689 | -19 | ||
| 2021Q1 | 7.61 | -0.23 | -17,251 | -17 |